- Home
- TYRA vs EXTO Comparison
TYRA vs EXTO Comparison
Compare TYRA & EXTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- EXTO
- Stock Information
- Founded
- TYRA 2018
- EXTO 1949
- Country
- TYRA United States
- EXTO Colombia
- Employees
- TYRA N/A
- EXTO N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- EXTO
- Sector
- TYRA Health Care
- EXTO
- Exchange
- TYRA Nasdaq
- EXTO Nasdaq
- Market Cap
- TYRA 812.7M
- EXTO 689.5M
- IPO Year
- TYRA 2021
- EXTO N/A
- Fundamental
- Price
- TYRA $14.00
- EXTO $3.85
- Analyst Decision
- TYRA Strong Buy
- EXTO
- Analyst Count
- TYRA 5
- EXTO 0
- Target Price
- TYRA $31.00
- EXTO N/A
- AVG Volume (30 Days)
- TYRA 219.5K
- EXTO 35.2K
- Earning Date
- TYRA 11-07-2024
- EXTO 01-01-0001
- Dividend Yield
- TYRA N/A
- EXTO 1.58%
- EPS Growth
- TYRA N/A
- EXTO N/A
- EPS
- TYRA N/A
- EXTO 0.01
- Revenue
- TYRA N/A
- EXTO $5,038,935,945.00
- Revenue This Year
- TYRA N/A
- EXTO $0.80
- Revenue Next Year
- TYRA N/A
- EXTO $3.07
- P/E Ratio
- TYRA N/A
- EXTO $94.72
- Revenue Growth
- TYRA N/A
- EXTO N/A
- 52 Week Low
- TYRA $11.24
- EXTO $3.69
- 52 Week High
- TYRA $29.60
- EXTO $7.30
- Technical
- Relative Strength Index (RSI)
- TYRA 32.68
- EXTO 46.70
- Support Level
- TYRA $14.65
- EXTO $3.81
- Resistance Level
- TYRA $15.55
- EXTO $4.08
- Average True Range (ATR)
- TYRA 0.72
- EXTO 0.13
- MACD
- TYRA 0.02
- EXTO 0.01
- Stochastic Oscillator
- TYRA 3.12
- EXTO 41.49
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).
About EXTO Almacenes Exito S.A. each representing eight (8)
Almacenes Exito SA is a Colombian retailer that operates in its homeland and overseas. The company operates under three reportable segments Grupo Exito, Carulla, Low cost, and others in Colombia; Libertad in Argentina; and Disco, Devoto, and Geant chains in Uruguay. Exito has an omnichannel, multiformat, and multibrand model. Its store offerings include groceries and food, clothing, home appliances, oil-based liquid fuels, biofuels, personal care products, and home entertainment electronic and digital products.